D. Anderson & Company Among Top Women-Owned Businesses in Dallas
D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008.
November 10, 2008 D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008. The Dallas Business Journal bestows the coveted honor each year based on annual revenues and company size. Of 29,959 women-owned businesses in Dallas, according to the U.S. Census Bureau, DAC ranks 47th in terms of profits and personnel. President and CEO Diana Anderson, Ph.D., has positioned DAC as an international player boasting expertise in several therapeutic areas. The company began more than 18 years ago as a site management organization and evolved into one of the largest privately held patient recruitment and retention firms in the United States. DAC’s client list includes leading biotechnology and pharmaceutical companies worldwide. But it doesn’t end there. Urban hospitals, community clinics and private physicians call on DAC for strategic direction. The company reinforces its position as a thought leader by addressing delegates at key industry conferences worldwide and publishing authoritative books and articles. In 2007, DAC released “International Patient Recruitment Regulatory Guidelines, Customs and Practices,” which provides an expository view of legislation governing patient recruitment in 23 countries. This editorial endeavor elevated DAC’s profile on the international circuit. DAC is headquartered in Dallas with affiliate offices in Houston, Seattle and Windsor, U.K. For more information, visit www.dandersoncompany.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
